Epstein-Barr Virus (EBV)

Researchers are advancing toward a vaccine for the Epstein-Barr virus (Epstein-Barr virus), a highly contagious virus that infects nearly 95% of the global population and is linked to serious diseases like Burkitt’s lymphoma, stomach cancer, and multiple sclerosis.
Epstein-Barr Virus (EBV)
Transmission: Through bodily fluids, mainly saliva
Population: Most people are infected, often in childhood or young adulthood
Virus may reactivate under immune stress, potentially causing cancers and autoimmune conditions 
No specific antiviral treatment exists
The development of a vaccine could prevent widespread infections and reduce the risk of EBV-related diseases globally.